DS Healthcare Continues Expansion into Middle East

Pompano Beach, Fla., June 22, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX), DS Healthcare Group today announced it has finalized a distribution agreement in Egypt with MultiTrade, a distributor of pharmaceutical products. MultiTrade has placed orders for immediate delivery to begin supplying customers in the region.

MultiTrade is a leading distributor of pharmaceutical and biological products to healthcare professionals in Egypt. With a strong focus on education and commitment to maintaining a highly skilled workforce, MultiTrade has had rapid growth since their formation in 2006. DS Healthcare products will be supplied to physicians and other healthcare professionals to meet the growing demand for high efficacy topical formulations and drug therapies.

“Following our product registrations in the Middle East, we are beginning to see growing demand from this region. We expect Egypt to be a very lucrative market and we think MultiTrade is the ideal partner for us with their distribution network, professional staff, and long term commitment to DS Healthcare” stated DS Healthcare’s President and CEO Daniel Khesin.

Commenting on the launch of DS Healthcare products Chief Executive Officer of MultiTrade Mr. Ali stated “I’m thrilled to represent DS Healthcare. These products are an important addition to our portfolio of topical products for physicians. The innovation and efficacy of these products is unmatched. The medical community is eager to begin recommending these treatments for patients”.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com

About MultiTrade

A holding company with a team of more than 150 professional and specialized staff servicing healthcare professionals in Egypt. MultiTrade is a leading supplier of a wide range of pharmaceutical products, and biological products. The company maintains a commitment to innovation, collaboration, patient focus & ongoing drive for excellence,

For more information, visit www.multitrade-mena.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.

Abner Silva DS Healthcare Group 407.342.4112 Abner@DSHealthgroup.com

Source:DS Healthcare Group, Inc.